Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy

To predict prostate cancer and its prognosis by ultrasound radiomics in ultrasound fusion prostate targeted biopsy.

Inclusion Criteria:Age ≥55 years old.Patients had multiparametric magnetic resonance imaging (mpMRI) data within 3 months before biopsy and tPSA/fPSA within 1 month before biopsy.Patients had any of the following indications for prostate biopsy:Suspicious prostate nodules were found by digital rectal examinationSuspicious lesions were detected by B-ultrasound or MRIPSA>10ng/mlPSA 4-10ng/ml, with abnormal f/tPSA and/or PSAD valuesExclusion Criteria:malignant tumors other than prostate adenocarcinoma indicated by pathology.Combined with other malignant tumors (such as rectal cancer, bladder cancer, testicular cancer, etc.) that may affect the imaging findings of transrectal ultrasound or mpMRI.Other conditions that would preclude needle biopsy: cachexia, decompensation of organ function, hemorrhagic diseases, local infection, etc